Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Immuron Limited ( (AU:IMC) ).
Immuron Limited has announced a proposed issue of 2,579,760 ordinary fully paid securities, with a proposed issue date of August 1, 2025. This strategic move aims to bolster the company’s financial position, potentially enhancing its market presence and offering new investment opportunities for stakeholders.
More about Immuron Limited
Immuron Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of oral immunotherapy products for the treatment of immune-mediated diseases.
YTD Price Performance: -2.50%
Average Trading Volume: 1,000
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €11.04M
See more insights into IMC stock on TipRanks’ Stock Analysis page.
